Feasibility of a Digital Therapeutic for Adults With Posttraumatic Stress Disorder (PTSD)

Launched by OUI THERAPEUTICS, INC. · Mar 5, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how well a digital therapeutic app can help adults with posttraumatic stress disorder (PTSD) feel better. The study aims to see if using this app can reduce symptoms of PTSD in people who have been diagnosed with this condition. It is currently not recruiting participants, but when it starts, it will welcome adults aged 18 and older who speak and understand English and have specific scores on PTSD assessments.

To be eligible for the study, participants need to have a confirmed PTSD diagnosis and meet certain scores on two tests that measure the severity of their symptoms. However, people who do not meet these criteria, have active psychosis, are under the influence of drugs, or are already participating in another treatment study will not be able to take part. If someone joins the trial, they can expect to use the app as part of their experience, which may help them manage their PTSD symptoms more effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Posttraumatic stress disorder (PTSD) diagnosis
• • Anxiety Sensitivity Index 3 (ASI-3) scores above 24
• • PTSD Checklist for DSM-V (PCL-5) scores above 30
• • Understands and speaks English
• • Access to a smartphone that is connected to the internet
• Exclusion Criteria:
• • Score of 24 or lower on the ASI-3
• • Score of 30 and below on the PCL-5
• • No PTSD diagnosis
• • Active psychosis
• • Acute intoxication during study baseline
• • Enrolled in another treatment research study
• • Medical illness that would prevent the completion of interoceptive exposure exercises